Community-acquired Staphylococcus aureus infections: Increasing virulence and emerging methicillin resistance in the new millennium

Current Opinion in Infectious Diseases

Volumn 16, Issue 3, 2003, Pages 189-191

  Stevens, Dennis L ^a,b  

^a Boise VA Medical Center   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CHLORAMPHENICOL; LEVOQUIN; METICILLIN; NAFCILLIN; OXACILLIN; PENICILLIN G; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

BACTERIAL STRAIN; BACTERIAL VIRULENCE; CATHETERIZATION; COMMUNICABLE DISEASE; DEVICE INFECTION; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; GENETIC PREDISPOSITION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; PREVALENCE; PROPHYLAXIS; RISK FACTOR; STAPHYLOCOCCUS INFECTION; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0038621435     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200306000-00001     Document Type: Editorial

References (16)

1. Everett ED, McNitt TR, Rahm AE, et al. Epidemiologic investigation of methicillin resistant Staphylococcus aureus in a burn unit. Military Med 1978; 143:165-167.
2. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002; 49:999-1005.
3. Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002; 186:1344-1347.
4. Centers for Disease Control. From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. JAMA 1999; 282:1123-1125.
5. Charlebois IE, Perdreau-Remington F. Molecular evidence for clonal distinction between community and nosocomial methicillin-resistant Staphylococcus aureus in 536 clinical infections [abstract 23]. In: Program and Abstracts of the 40th Annual Infectious Disease Society of America Meeting; October 24-27; Chicago, IL. Alexandria, Virginia, Infectious Diseases Society of America; 2002.
6. Campbell A, Bryant K, Stover B, et al. Epidemiology of Staphylococcus aureus infection at a children's hospital [abstract 620]. In: Program and Abstracts of the 40th Annual Infectious Disease Society of America Meeting; October 24-27; Chicago, IL.; Alexandria, Virginia, Infectious Diseases Society of America; 2002.
7. Dietrich DW, Auld DB, Mermel L. Pediatric community-acquired methicillin-resistant Staphylococcus aureus in southeastern New England [abstract 617]. in: Program and Abstracts of the 40th Annual Infectious Disease Society of America Meeting; October 24-27; Chicago, IL; Alexandria, Virginia, Infectious Diseases Society of America; 2002.
8. Purcell RK, Fergie JE. Exponential increase in community-acquired MRSA infections in South Texas children [abstract 618]. In: Program and Abstracts of the 40th Annual Infectious Disease Society of America Meeting; October 24-27; Chicago, IL; Alexandria, Virginia, Infectious Diseases Society of America; 2002.
9. Schmitz FJ, MacKenzie CR, Geisel R, et al. Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strain. Eur J Epidemiol 1997; 13:699-708.
10. Fujiwara Y, Endo S. A case of toxic shock syndrome secondary to mastitis caused by methicillin-resistant Staphylococcus aureus. Kansenshogaku Zasshi 2001; 75:898-903.
11. Amano T, Imao T, Fukuda M, et al. Toxic shock syndrome due to methicillin resistant staphylococcus aureus (MRSA) after total prostatectomy. Nippon Hinyokika Gakkai Zasshi 2002; 93:44-47.
12. Nakano M, Miyazawa H, Kawano Y, et al. An outbreak of neonatal toxic shock syndrome-like exanthematous disease (NTED) caused by methicillin-resistant Staphylococcus aureus (MRSA) in a neonatal intensive care unit. Microbiol Immunol 2002; 46:277-284.
13. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35:819-824.
14. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gone for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359:753-759.
15. Lina F, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leuocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 2003; 29:1128-1132.
16. Baggett H, Rudolph K, Hennessy T, et al. Panton-Valentine leukocidin (PVL) is associated with methicillin resistance in an outbreak of community-onset Staphylococcus aureus skin infections: Alaska [abstract 126]. In: Program and Abstracts of the 40th Annual Infectious Disease Society of America Meeting; October 24-27; Chicago, IL, Alexandria, Virginia, Infectious Diseases Society of America; 2002.